OpenAI sued; complaint says ChatGPT advised an Amazon engineer to stop taking anti-seizure medication

Bowen Wan's family sued OpenAI, alleging that ChatGPT advised the Amazon engineer to reduce her anti-seizure medication dose against medical advice and said before her death that her head pain was not dangerous. According to The New York Times' review of more than 270,000 messages between Wan and ChatGPT, ChatGPT had been involved in her medical decisions months before her death, helping her draft requests to change or lower her medication and saying doctors' recommendations were essentially driven by risk aversion rather than what was best for her. The lawsuit argues that OpenAI should make such medication advice a hard safety restriction; OpenAI expressed sympathy for Wan's death but noted that she was using an older version of ChatGPT and that newer versions are better at recognizing serious situations. The report also mentions that OpenAI announced it would retire GPT-4o on February 13, one day after Wan's death, and links this case to the earlier Adam Raine case, in which his parents allege the chatbot was connected to their 16-year-old son's suicide.